Locations:

Tag: brian hill

December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

January 24, 2019/Cancer/Blood Cancers

Additions to R-CHOP in Patients with Diffuse or Aggressive Large B-Cell Lymphoma

Genetics affect how patients respond

December 3, 2018/Cancer/Research

More Evidence that CAR T-Cell Therapy Works for Many Patients with Large B-Cell Lymphoma

High-risk and real-world patients responded

June 26, 2018/Cancer/Blood Cancers

Cancer Center Offers Chimeric Antigen Receptor T-Cell Therapy

Cleveland Clinic's approach to the therapy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 11, 2017/Cancer/Research

Long-Term Follow-Up of ZUMA-1 Shows Significant Clinical Benefit (Video)

Anti-CD19 CAR T cell therapy an option for patients with no others

December 10, 2017/Cancer/Research

Autologous Hematopoietic Cell Transplant Improves Survival in Mantle Cell Lymphoma

Multicenter study shows survival benefit for patients ≤ 65

April 9, 2015/Cancer/News & Insight

FDA OKs Zarxio as First Biosimilar Drug

Approval may spur competition, cost savings

BackPage 1 of 1Next